|28.91||+0.12 / +0.42%|
Data as of 4:00pm ET
|29.02||+0.1145 / +0.40%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 30.00, with a high estimate of 33.00 and a low estimate of 27.00. The median estimate represents a +3.77% increase from the last price of 28.91.
The current consensus among 5 polled investment analysts is to Hold stock in Natus Medical Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.